Globe Life (NYSE:GL) Hits New 52-Week High – Time to Buy?

Globe Life Inc. (NYSE:GL)’s share price reached a new 52-week high on Wednesday . The company traded as high as $181.33 and last traded at $180.8140, with a volume of 73595 shares trading hands. The stock had previously closed at $178.68.

Analyst Ratings Changes

A number of research firms recently commented on GL. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. Wells Fargo & Company increased their price objective on Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a report on Friday, April 10th. Keefe, Bruyette & Woods reissued a “moderate buy” rating and issued a $168.00 target price on shares of Globe Life in a research report on Thursday, March 26th. TD Cowen boosted their target price on Globe Life from $199.00 to $215.00 and gave the company a “buy” rating in a research note on Tuesday, June 23rd. Finally, Texas Capital upgraded Globe Life to a “strong-buy” rating in a research note on Wednesday, March 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $175.89.

Globe Life Trading Up 0.2%

The firm’s 50-day moving average price is $160.62 and its 200-day moving average price is $148.63. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. The company has a market cap of $14.01 billion, a P/E ratio of 12.48 and a beta of 0.47.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The business had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period last year, the business posted $3.07 earnings per share. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, equities research analysts expect that Globe Life Inc. will post 15.64 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is presently 9.13%.

Insider Buying and Selling

In related news, CEO Frank M. Svoboda sold 20,000 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the sale, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. This represents a 27.02% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael Clay Majors sold 34,000 shares of the firm’s stock in a transaction dated Friday, April 24th. The stock was sold at an average price of $153.81, for a total value of $5,229,540.00. Following the completion of the transaction, the executive vice president owned 53,518 shares of the company’s stock, valued at approximately $8,231,603.58. This represents a 38.85% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 124,187 shares of company stock valued at $19,529,414 in the last 90 days. Corporate insiders own 2.11% of the company’s stock.

Institutional Trading of Globe Life

Hedge funds and other institutional investors have recently bought and sold shares of the company. CX Institutional boosted its holdings in Globe Life by 9.2% in the 2nd quarter. CX Institutional now owns 3,022 shares of the company’s stock valued at $540,000 after purchasing an additional 255 shares during the period. Parallel Advisors LLC increased its holdings in shares of Globe Life by 6.4% in the first quarter. Parallel Advisors LLC now owns 1,756 shares of the company’s stock worth $244,000 after purchasing an additional 105 shares during the period. Glenmede Trust Co. NA increased its holdings in shares of Globe Life by 5.8% in the first quarter. Glenmede Trust Co. NA now owns 7,396 shares of the company’s stock worth $1,029,000 after purchasing an additional 406 shares during the period. Groupama Asset Managment purchased a new stake in shares of Globe Life in the first quarter worth $466,000. Finally, Edgestream Partners L.P. purchased a new stake in shares of Globe Life in the first quarter worth $7,513,000. Institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.